Followers | 829 |
Posts | 119663 |
Boards Moderated | 16 |
Alias Born | 09/05/2002 |
Thursday, January 18, 2024 6:33:20 PM
https://finance.yahoo.com/news/aeon-biopharma-presents-positive-clinical-210500488.html
CD had been AEON’s lead indication for ABP-450, but AEON changed gears and made episodic migraine the lead indication after RVNC reported Daxxify data in CD (https://www.sec.gov/Archives/edgar/data/1837607/000110465923063774/tm2316532d1_ex99-1.htm ). When AEON’s phase-2 in episodic migraine failed in Oct 2023 (#msg-173058579), CD again became the lead indication by default.
The above PR also includes preclinical data for ABP-450 in PTSD (!?).
AEON needs to raise a significant amount of cash to conduct a phase-3 trial in any indication (#msg-173211412).
Reminder: ABP-450, sourced from Korea’s Daewoong, is the exact same toxin as EOLS’ Jeuveau. See #msg-172274907 for background info.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent AEON News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:27:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:07:43 PM
- Form ARS/A - Annual Report to Security Holders: [Amend] • Edgar (US Regulatory) • 05/14/2024 01:15:36 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/14/2024 01:14:35 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/14/2024 01:05:41 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/23/2023 02:48:14 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 02:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 08:23:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 09:06:34 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/18/2023 09:27:03 PM
- Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma • GlobeNewswire Inc. • 08/16/2023 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/12/2023 01:12:00 AM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM